Skip to main content
Log in

Percutaneous Irreversible Electroporation Lung Ablation: Preliminary Results in a Porcine Model

  • Laboratory Investigation
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Objective

Irreversible electroporation (IRE) uses direct electrical pulses to create permanent “pores” in cell membranes to cause cell death. In contrast to conventional modalities, IRE has a nonthermal mechanism of action. Our objective was to study the histopathological and imaging features of IRE in normal swine lung.

Materials and Methods

Eleven female swine were studied for hyperacute (8 h), acute (24 h), subacute (96 h), and chronic (3 week) effects of IRE ablation in lung. Paired unipolar IRE applicators were placed under computed tomography (CT) guidance. Some applicators were deliberately positioned near bronchovascular structures. IRE pulse delivery was synchronized with the cardiac rhythm only when ablation was performed within 2 cm of the heart. Contrast-enhanced CT scan was performed immediately before and after IRE and at 1 and 3 weeks after IRE ablation. Representative tissue was stained with hematoxylin and eosin for histopathology.

Results

Twenty-five ablations were created: ten hyperacute, four acute, and three subacute ablations showed alveolar edema and necrosis with necrosis of bronchial, bronchiolar, and vascular epithelium. Bronchovascular architecture was maintained. Chronic ablations showed bronchiolitis obliterans and alveolar interstitial fibrosis. Immediate post-procedure CT images showed linear or patchy density along the applicator tract. At 1 week, there was consolidation that resolved partially or completely by 3 weeks. Pneumothorax requiring chest tube developed in two animals; no significant cardiac arrhythmias were noted.

Conclusion

Our preliminary porcine study demonstrates the nonthermal and extracellular matrix sparing mechanism of action of IRE. IRE is a potential alternative to thermal ablative modalities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Davalos RV, Mir IL, Rubinsky B (2005) Tissue ablation with irreversible electroporation. Ann Biomed Eng 33(2):223–231

    Article  PubMed  CAS  Google Scholar 

  2. Edd JF, Horowitz L, Davalos RV et al (2006) In vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Trans Biomed Eng 53(7):1409–1415

    Article  PubMed  Google Scholar 

  3. Garcia PA, Rossmeisl JH Jr, Robertson J et al (2009) Pilot study of irreversible electroporation for intracranial surgery. Conf Proc IEEE Eng Med Biol Soc 2009:6513–6516

    PubMed  Google Scholar 

  4. Maor E, Ivorra A, Leor J et al (2007) The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat 6(4):307–312

    PubMed  Google Scholar 

  5. Rubinsky B (2007) Irreversible electroporation in medicine. Technol Cancer Res Treat 6(4):255–260

    PubMed  Google Scholar 

  6. Rubinsky B, Onik G, Mikus P (2007) Irreversible electroporation: a new ablation modality―clinical implications. Technol Cancer Res Treat 6(1):37–48

    PubMed  Google Scholar 

  7. Neumann E, Schaefer-Ridder M, Wang Y et al (1982) Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1(7):841–845

    PubMed  CAS  Google Scholar 

  8. Weaver JC (2000) Electroporation of cells and tissues. IEEE Trans Plasma Sci IEEE Nucl Plasma Sci Soc 28:24–33

    Article  CAS  Google Scholar 

  9. Mir LM (2001) Therapeutic perspectives of in vivo cell electropermeabilization. Bioelectrochemistry 53(1):1–10

    Article  PubMed  CAS  Google Scholar 

  10. Miller L, Leor J, Rubinsky B (2005) Cancer cells ablation with irreversible electroporation. Technol Cancer Res Treat 4(6):699–705

    PubMed  Google Scholar 

  11. Rubinsky J, Onik G, Mikus P et al (2008) Optimal parameters for the destruction of prostate cancer using irreversible electroporation. J Urol 180(6):2668–2674

    Article  PubMed  Google Scholar 

  12. Lee EW, Loh CT, Kee ST (2007) Imaging guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation. Technol Cancer Res Treat 6(4):287–294

    PubMed  Google Scholar 

  13. Lencioni R, Cioni D, Pina CD et al (2009) Hepatocellular carcinoma: new options for image-guided ablation. J Hepatobiliary Pancreat Surg 17(4):399–403

    Article  Google Scholar 

  14. Vogl TJ, Naguib NN, Lehnert T et al (2009) Radiofrequency, microwave and laser ablation of pulmonary neoplasms: clinical studies and technical considerations. Eur J Radiol 77(2):346–357

    Article  PubMed  Google Scholar 

  15. Wang H, Littrup PJ, Duan Y et al (2005) Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures. Radiology 235(1):289–298

    Article  PubMed  Google Scholar 

  16. Sano Y, Kanazawa S, Gobara H et al (2007) Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies: a large single-center experience. Cancer 109(7):1397–1405

    Article  PubMed  Google Scholar 

  17. Sakurai J, Hiraki T, Mukai T et al (2007) Intractable pneumothorax due to bronchopleural fistula after radiofrequency ablation of lung tumors. J Vasc Interv Radiol 18(1 Pt 1):141–145

    Article  PubMed  Google Scholar 

  18. Kodama H, Yamakado K, Murashima S et al (2009) Intractable bronchopleural fistula caused by radiofrequency ablation: endoscopic bronchial occlusion with silicone embolic material. Br J Radiol 82(983):e225–e227

    Article  PubMed  CAS  Google Scholar 

  19. Steinke K, Haghighi KS, Wulf S et al (2005) Effect of vessel diameter on the creation of ovine lung radiofrequency lesions in vivo: preliminary results. J Surg Res 124(1):85–91

    Article  PubMed  Google Scholar 

  20. Steinke K, Arnold C, Wulf S et al (2003) Safety of radiofrequency ablation of myocardium and lung adjacent to the heart: an animal study. J Surg Res 114(2):140–145

    Article  PubMed  Google Scholar 

  21. Brace CL, Hinshaw JL, Laeseke PF et al (2009) Pulmonary thermal ablation: comparison of radiofrequency and microwave devices by using gross pathologic and CT findings in a swine model. Radiology 251(3):705–711

    Article  PubMed  Google Scholar 

  22. Lu DS, Raman SS, Limanond P et al (2003) Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol 14(10):1267–1274

    PubMed  Google Scholar 

  23. Oshima F, Yamakado K, Akeboshi M et al (2004) Lung radiofrequency ablation with and without bronchial occlusion: experimental study in porcine lungs. J Vasc Interv Radiol 15(12):1451–1456

    PubMed  Google Scholar 

  24. Deodhar A, Dickfeld T, Single GW et al (2011) Irreversible electroporation near the heart: ventricular arrhythmias can be prevented with ECG synchronization. AJR Am J Roentgenol 196(3):W330–W335

    Article  PubMed  Google Scholar 

  25. Davalos RV, Rubinsky B, Mir LM (2003) Theoretical analysis of the thermal effects during in vivo tissue electroporation. Bioelectrochemistry 61(1–2):99–107

    Article  PubMed  CAS  Google Scholar 

  26. Deodhar A, Monette S, Single GW et al (2011) Renal tissue ablation with irreversible electroporation: preliminary results in a porcine model. Urology 77(3) (in press)

  27. Steinke K, Glenn D, King J et al (2004) Percutaneous imaging-guided radiofrequency ablation in patients with colorectal pulmonary metastases: 1-year follow-up. Ann Surg Oncol 11(2):207–212

    Article  PubMed  Google Scholar 

  28. Bojarski JD, Dupuy DE, Mayo-Smith WW (2005) CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumors. AJR Am J Roentgenol 185(2):466–471

    PubMed  Google Scholar 

  29. Smith S, Gillams A (2008) Imaging appearances following thermal ablation. Clin Radiol 63(1):1–11

    Article  PubMed  CAS  Google Scholar 

  30. Ohno Y, Hatabu H, Takenaka D et al (2003) CT-guided transthoracic needle aspiration biopsy of small (< or = 20 mm) solitary pulmonary nodules. AJR Am J Roentgenol 180(6):1665–1669

    PubMed  Google Scholar 

  31. Gibson TB (2006) Radiofrequency ablation for patients with colorectal cancer and unresectable liver metastasis. Clin Colorectal Cancer 5(5):318–320

    Article  PubMed  Google Scholar 

  32. Steinke K, Gananadha S, King J et al (2003) Dispersive pad site burns with modern radiofrequency ablation equipment. Surg Laparosc Endosc Percutan Technol 13(6):366–371

    Article  Google Scholar 

  33. Wolf FJ, Grand DJ, Machan JT et al (2008) Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients. Radiology 247(3):871–879

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This porcine study was supported by a research fund from Angiodynamics Inc, NY.

Conflict of interest

Research funds were provided by Angiodynamics, Inc. Queensbury, NY; S. S. is a scientific advisor to Angiodynamics Inc.; and G. S and W. H. are employees of Angiodynamics, Inc.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stephen B. Solomon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Deodhar, A., Monette, S., Single, G.W. et al. Percutaneous Irreversible Electroporation Lung Ablation: Preliminary Results in a Porcine Model. Cardiovasc Intervent Radiol 34, 1278–1287 (2011). https://doi.org/10.1007/s00270-011-0143-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-011-0143-9

Keywords

Navigation